AEHR — AEHR Test Systems Income Statement
0.000.00%
Last trade - 00:00- $1.75bn
- $1.63bn
- $50.00m
Annual income statement for AEHR Test Systems, fiscal year end - May 29th, USD millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 30th | 2026 May 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 50.8 | 65 | 66.2 | 59 | 50 |
| Cost of Revenue | |||||
| Gross Profit | 23.7 | 32.7 | 32.5 | 23.9 | 17.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 41.3 | 51.6 | 56.1 | 64.6 | 64.2 |
| Operating Profit | 9.5 | 13.4 | 10.1 | -5.68 | -14.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.54 | 14.6 | 12.5 | -4.29 | -11.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.45 | 14.6 | 33.2 | -3.91 | -7.13 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.45 | 14.6 | 33.2 | -3.91 | -7.13 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.45 | 14.6 | 33.2 | -3.91 | -7.13 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.28 | 0.498 | 1.12 | -0.113 | -0.232 |